Of the multiple fibroblast growth factors with known roles in AKI, FGF-23 and its co-receptor Klotho have been implicated as potential predictive and prognostic biomarkers for AKI (Christov et al. 2019). This evidence concerns the gene FGF23 and acute kidney injury.